Extramedullary myeloid cell tumors arising in the setting of chronic myelomonocytic leukemia: A report of two cases

Archives of Pathology and Laboratory Medicine

Volumn 120, Issue 1, 1996, Pages 62-67

  Elenitoba Johnson, Kojo ^a,b   Hodges, George F ^c,d   King, Thomas C ^a,b   Wu, C Daniel ^a   Medeiros, L Jeffrey ^a,e  

^a RHODE ISLAND HOSPITAL   (United States)

^b ROGER WILLIAMS MEDICAL CENTER   (United States)

^c BROWN UNIVERSITY   (United States)

^d Pathol Associates of Tacoma PS   (United States)

^e CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOSIALIN; LYSOZYME; MYELOPEROXIDASE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANEMIA; ARTICLE; BLAST TRANSFORMATION; BONE MARROW CELL; CANCER CYTODIAGNOSIS; CASE REPORT; CHRONIC MYELOMONOCYTIC LEUKEMIA; HUMAN; HUMAN TISSUE; MALE; MYELODYSPLASTIC SYNDROME;

EID: 0030068422     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Zittoun R. Chronic myelomonocytic leukemia. In: The Myelodysplastic Syndromes. Mufti GJ, Galton DAG, eds. New York, NY: Churchill Livingstone; 1992: 65-88.
2. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982;51:189-199.
3. Brunning RD. Myelodysplastic syndromes. In: Knowles DM, ed. Neoplastic Hematopathology. Baltimore, Md: Williams and Wilkins; 1992:1376-1391.
4. Geary CG, Catovsky D, Wiltshaw E, et al. Chronic myelomonocytic leukaemia. Br J Haematol. 1975;30:289-302.
5. Kerkhofs H, Hermans J, Haak HL, Leeksma CHW. Utility of the FAB classification for myelodysplastic syndromes: investigation of prognostic factors in 237 cases. Br J Haematol. 1987;65:73-81.
6. Vallespi T, Torrabadella M, Julia A, et al. Myelodysplastic syndromes: a study of 101 cases according to the FAB classification. Br J Haematol. 1985;61:83-92.
7. Solal-Celigny P, Desaint B, Herrera A, et al. Chronic myelomonocytic leukemia according to FAB classification: analysis of 35 cases. Blood. 1984;63:634-638.
8. Tefferi A, Hoagland HC, Therneau TM, Pierre RV. Chronic myelomonocytic leukemia: natural history and prognostic determinants. Mayo Clin Proc. 1989;64: 1246-1254.
9. Duguid JKM, Mackie MJ, McVerry BA. Skin infiltration associated with chronic myelomonocytic leukemia. Br J Haematol. 1983;53:257-264.
10. Orita M, Iwahana H, Knazawa H, Hayashi K, Sekey T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA. 1989;86:2766-2770.
11. Meis JM, Butler JJ, Osborne BM, Manning JT. Granulocytic sarcoma in nonleukemic patients. Cancer. 1986;58:2697-2709.
12. Neiman RS, Barcos M, Berard C, et al. Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases. Cancer. 1981;48:1426-1437.
13. Rappaport H. Atlas of Tumor Pathology: Tumors of the Hematopoietic System. Washington, DC: Armed Forces Institute of Pathology; 1966:241-243.
14. Peterson L, Dehner LP, Brunning RD. Extramedullary masses as presenting features of acute monoblastic leukemia. Am J Clin Pathol. 1981;75:140-148.
15. Davey FR, Olson S, Kurec AS, Eastman-Abaya R, Gottlieb AJ, Mason DY. The immunophenotyping of extramedullary myeloid cell tumors in paraffin-embedded tissue sections. Am J Surg Pathol. 1988;12:699-707.
16. Traweek ST, Arber DA, Rappaport H, Brynes RK. Extramedullary myeloid cell tumors: an immunohistochemical and morphologic study of 28 cases. Am J Surg Pathol. 1993;17:1011-1019.
17. Fellbaum C, Hansmann M-L. Immunohistochemical differential diagnosis of granulocytic sarcomas and malignant lymphomas on formalin-fixed material. Virchows Arch A Pathol Anat Histopathol. 1990;416:351-355.
18. Elliott CJ, McCarthy KP, Carter RL, Davies P. Granulocytic sarcoma: misleading immunological staining with MT1 and S100 protein antibodies. J Clin Pathol. 1989;42:188-190.
19. Segal GH, Stoler MH, Tubbs RR. The 'CD43 only' phenotype: an aberrant nonspecific immunophenotype requiring comprehensive analysis for lineage resolution. Am J Clin Pathol. 1992;97:861-865.
20. Hudock J, Chatten J, Miettinen M. Immunohistochemical evaluation of myeloid leukemia infiltrates (granulocytic sarcomas) in formaldehyde-fixed and paraffin-embedded tissue. Am J Clin Pathol. 1994;102:55-60.
21. Ritter JH, Goldstein NS, Argenyi Z, Wick MR. Granulocytic sarcoma: an immunologic comparison with peripheral T-cell lymphoma in paraffin sections. J Cut Pathol. 1994;21:207-216.
22. Kitagawa M, Yoshida S, Kuwata T, Tanizawa T, Kamiyama R. p53 expression in myeloid cells of myelodysplastic syndromes: association with evolution of overt leukemia. Am J Pathol. 1994;145:338-344.
23. Sugimoto K, Hirano N, Toyoshima H, et al. Mutations of the p53 gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia. Blood. 1993;81: 3022-3026.
24. Slingerland JM, Minden MD, Benchimol S. Mutation of the p53 gene in human acute myelogenous leukemia. Blood 1991;77:1500-1507.
25. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 1991;51:6304-6311.